Updates in Hereditary Angioedema Care from the HAEA

Program Overview

This activity will cover HAE genetics and diagnostics with a focus on HAE-nl-C1INH, emerging therapies, and patient-centered care.

Credit Expired
1.0 CE Credit(s)
Expires: November 29, 2024

Target Audience

This activity is designed to meet the educational needs of clinicians involved in the diagnosis and management of patients with hereditary angioedema (HAE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Integrate new developments in hereditary angioedema (HAE) genetic and diagnostic testing
  • Utilize clinical guidelines to select treatment for prophylaxis and acute attacks in patients with HAE
  • Provide patient-centered care using individualized management plans and educational resources

Activity Faculty

Castaldo-photo1

Anthony J. Castaldo

President/CEO
US HAEA
Fairfax City, VA

Zuraw-photo2

Bruce L. Zuraw, MD

Professor, Medicine, UCSD Department of Medicine
Director, US HAE Angioedema Center at UCSD University of California School of Medicine
La Jolla, CA
Research Scientist, Veterans Medical Research Foundation
VA Staff Physician and Chief, Section of Allergy San Diego
Veterans Affairs Medical Center
San Diego, CA

Banerji-photo3

Aleena Banerji, MD

Associate Professor, Medicine
Harvard Medical School
Program and Assistant Clinical Director
Allergy and Immunology Training Program Division of Rheumatology, Allergy and Immunology
Massachusetts General Hospital
Boston, MA

Lumry photo 2021

William R. Lumry, MD

Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX

Riedl Photo 300 dpi (1)

Marc A. Riedl, MD, MS

Professor, Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief, Allergy & Immunology
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Provider Statement 

Jointly provided by RMEI Medical Education, LLC and the US Hereditary Angioedema Association (HAEA). 

Supporter Statement 

Funding provided by the US Hereditary Angioedema Association (HAEA). No commercial support provided for this accredited continuing education activity. 

Disclosure of Financial Relationships 

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 

Faculty 

Anthony J. Castaldo,  has no relevant financial relationship(s) with ineligible companies to disclose. 

Aleena Banerji, MD, has relevant financial relationships with BioCryst Pharmaceuticals, Ionis Pharmaceuticals, Inc., KalVista Pharma, Pharvaris, Takeda (Consultant); BioCryst Pharmaceuticals, Ionis Pharmaceuticals, Inc., KalVista Pharma, Takeda (Researcher). 

William R. Lumry, MD, has relevant financial relationships with Astria, BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Express Scripts/CVS, Fresenius Kabi, Intellia Therapeutics, Inc., KalVista Pharma, Magellan, Optum, Pharming Group N.V., Pharvaris, Shire, Takeda (Consultant); CSL Behring, Grifols S.A., Ionis Pharmaceuticals, Inc., KalVista Pharma, Shire/Takeda, Teva Pharmaceuticals USA (Grant/Research Support); AstraZeneca, BioCryst Pharmaceuticals, CSL Behring, Grifols S.A., GSK, OptiNose, Inc, Pharming Group N.V., Shire/Takeda, Sanofi/Regeneron (Speakers’ Bureau). 

Marc A. Riedl, MD, MS, has relevant financial relationships with Astria, BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Cycle Pharmaceuticals Ltd, Grifols S.A., Intellia Therapeutics, Inc., Ipsen, KalVista Pharma, Ono Pharmaceutical Co., Ltd, Pfizer, Pharming Group N.V., Pharvaris, REGENXBIO Inc., Sanofi/Regeneron, Spark, Takeda (Consultant); BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Ionis Pharmaceuticals, Inc., KalVista Pharma, Pharvaris, Takeda (Grant/Research Support); Grifols S.A., Pharming Group N.V., Takeda (Speaker/Speakers’ Bureau). 

Bruce L. Zuraw, MD, has relevant financial relationships with BioCryst Pharmaceuticals, CSL Behring, Takeda (Consultant); Ionis Pharmaceuticals, Inc. (Independent Contractor, including Contracted Research); BioMarin Pharmaceuticals Inc., Genentech, Novartis (Other, Data Safety Monitoring). 

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies. 

Planners and Managers 
All planners and managers have no relevant financial relationship(s) with ineligible companies to disclose. 

Joint Accreditation Statement 

In support of improving patient care, this activity has been planned and implemented by RMEI Medical Education, LLC and the US Hereditary Angioedema Association (HAEA). RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Designation of Credit 

Physician Continuing Medical Education 
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Continuing Pharmacy Education 
RMEI Medical Education, LLC designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008290-9999-23-003-H01-P)
Type of Activity: Knowledge
 

Continuing Nursing Education 
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s). 

Instructions for Receiving Credit 

In order to receive credit, participants must review the activity content and complete the evaluation. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation and attest to credit

 
There is no fee to participate. 

Your Feedback is Important! 


COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!

*The expense for this gift card is solely funded by RMEI Medical Education, LLC. 
No supporter funding was used for the expense of this gift card. 

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card. 

Disclosure of Unlabeled Use 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Resources 

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources